Cite
HARVARD Citation
Ang, L. et al. (2020). Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer. Cancer letters. pp. 42-53. [Online].